Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1307969/000168316817000653/pharma024-20161231.htm
Document and Entity Information - USD ($) | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2016 | Oct. 20, 2017 | Mar. 24, 2017 | |
Document And Entity Information | |||
Entity Registrant Name | 024 Pharma, Inc. | ||
Entity Central Index Key | 0001307969 | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2016 | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --12-31 | ||
Is Entity a Well-known Seasoned Issuer? | No | ||
Is Entity a Voluntary Filer? | Yes | ||
Is Entity's Reporting Status Current? | No | ||
Entity Filer Category | Smaller Reporting Company | ||
Entity Public Float | $ 0 | ||
Entity Common Stock, Shares Outstanding | 336,354,321 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2016 |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1307969/000168316817000653/pharma024-20161231.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by 024 Pharma, Inc..
024 Pharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
024 Pharma, Inc. provided additional information to their SEC Filing as exhibits
Ticker: EEIG
CIK: 1307969
Form Type: 10-K Annual Report
Accession Number: 0001683168-17-000653
Submitted to the SEC: Fri Mar 24 2017 10:39:53 AM EST
Accepted by the SEC: Fri Mar 24 2017
Period: Saturday, December 31, 2016
Industry: Plastics Products